The company announced meetings with Institutional investors at the conferrence. That doesn't sound like a company that is on the verge of reporting a failed trial. In fact it is very encouraging, if Institutional investors get on board after the trial data is released it could be very good indeed.
- Forums
- ASX - By Stock
- ATH
- cowan conference
cowan conference
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATH (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
-0.001(25.0%) |
Mkt cap ! $15.96M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $15.14K | 5.049M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
79 | 104305685 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 979124 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
79 | 104305685 | 0.002 |
27 | 142640147 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 979124 | 2 |
0.004 | 153111101 | 60 |
0.005 | 8366584 | 12 |
0.006 | 16581534 | 13 |
0.007 | 53884874 | 26 |
Last trade - 13.58pm 13/11/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online